Epidemiology and Outcome of Fungemia in a Cancer Cohort of the Infectious Diseases Group (IDG) of the European Organization for Research and Treatment of Cancer (EORTC 65031)

Akan, H.; Akan, H.; Akan, Hamdi; Ameye, L.; Ameye, L.; Ameye, Lieveke; Bassetti, M.; Bassetti, M.; Bassetti, Matteo; Bille, J.; Bille, J.; Cornely, O. A.; Cornely, O. A.; Cornely, Oliver A.; de Burghgraeve, P.; de Burghgraeve, P.; de Burghgraeve, Peter; Donnelly, P. J.; Donnelly, P. J.; Donnelly, Peter J.; Gachot, B.; Gachot, B.; Gachot, Bertrand; Kibbler, C. C.; Kibbler, C. C.; Kibbler, Christopher; Marchetti, O.; Marchetti, O.; Marchetti, Oscar; Paesmans, M.; Paesmans, M.; Paesmans, Marianne; Pylkkanen, L.; Pylkkanen, L.; Pylkkanen, Liisa; Ramadan, Safaa; Uzun, O.; Uzun, O.; Uzun, Omrun

research

Epidemiology and Outcome of Fungemia in a Cancer Cohort of the Infectious Diseases Group (IDG) of the European Organization for Research and Treatment of Cancer (EORTC 65031)

Abstract

In a prospective cohort study of 145 030 admissions of cancer patients from 13 European Organisation for Research and Treatment of Cancer centers fungemia occurred in 0.23%. Candida albicans was the predominant pathogen. Fungemia was associated with substantial mortality. Antifungal prophylaxis and remission of cancer predicted better surviva

Similar works

Full text

Open in the Core reader

Download PDF

Available Versions

RERO DOC Digital Library

oai:doc.rero.ch:294530

Last time updated on 25/08/2017